amylin pharmaceuticals was a biopharmaceutical company based in san diego, ca, that was founded in 1987. the company was engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. amylin produced three drugs: symlin (pramlintide acetate), byetta (exenatide) and bydureon (exenatide extended-release).